NTRK1 and thyroid cancer: Phosphatidylinositol 3-kinase-protein kinase B/Akt (PI3K-PKB/Akt) pathway is continuously activated by some abnormal receptor tyrosine kinase (RTK), and gene mutation occurs in its downstream effectors, leading to high cell proliferation including thyroid cancer [56].